Classement en actions
#27702
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Capitalisation boursière
$31.27M
Changement (1 jour)
2.27%
Changement (1 an)
-61.30%
Le prix 461030 avec la capitalisation boursière de B
Capitalisation boursière de IMBdx(461030)
Capitalisation boursière: $31.27M
En August 2026, IMBdx a une capitalisation boursière de $31.27M. Cela fait de IMBdx la 27702nd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de IMBdx du 2024 au 2026
461030 par rapport au top 5 des plus populaires stocks
| Prix pour 461030 |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.301T
|
+16,949,060.58%
|
|
|
|
|
$4.634T
|
+14,816,374.31%
|
|
|
|
|
$4.143T
|
+13,246,795.96%
|
|
|
|
|
$3.589T
|
+11,476,672.38%
|
|
|
|
|
$2.857T
|
+9,134,796.65%
|
